| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/27/2002 | US6441009 Carboxyl pyridine derivatives chelate and inactivate the metals which can be carcinogenic or poisonous |
| 08/27/2002 | US6440980 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
| 08/27/2002 | US6440964 Containing antibiotics such as moxifloxacin; treating infections of microbacterium species microbacterium otitidis and microbacterium alconae |
| 08/27/2002 | US6440950 Selective and non-invasive visualization or treatment of vasculature |
| 08/27/2002 | US6440949 Method for promoting the growth of gram-positive bacilli and increasing the acidity in vagina |
| 08/27/2002 | US6440930 Protein formulations |
| 08/27/2002 | US6440743 Supplying immobilizated polynucleotides |
| 08/27/2002 | US6440513 Patch comprising cover foil, self-adhesive layer containing active agent, removable carrier material which extends beyond patch to form border having two spaced apart recesses from which respective end points of break line extend |
| 08/27/2002 | US6440493 Mixing solution of excipient dissolved in solvent with phase comprising immiscible solvent and surfactant to form emulsion of microdroplets, adding extraction phase comprising nonsolvent for excipient to harden drops, removing solvent |
| 08/27/2002 | US6440486 Method of depositing particles with an electrostatic chuck |
| 08/27/2002 | US6440463 Methods for fine powder formation |
| 08/27/2002 | US6440462 Agglomerates of β-lactam antibiotics and processess for making agglomerates |
| 08/27/2002 | US6440461 Drug delivery; biocompatibility, biodegradable |
| 08/27/2002 | US6440460 Controlled release; biodegradable; intraocular administering |
| 08/27/2002 | US6440459 Paroxetine maleate polymorph and pharmaceutical compositions containing it |
| 08/27/2002 | US6440458 Solid solution of tacrolimus or hydrate and hydroxypropyl cellulose |
| 08/27/2002 | US6440457 Administering venlafaxine antidepressant time-release agent; sustained release |
| 08/27/2002 | US6440454 Supersaturated solution of estradiol, progestogen, and activated silica; outer backing foil and protective lining |
| 08/27/2002 | US6440453 Transdermal systems for release of 5-HT3 receptor antagonists and their use in anti-emetic treatment |
| 08/27/2002 | US6440450 Soft chewable tablet comprising separated active ingredients |
| 08/27/2002 | US6440448 Plant and/or animal extract, antioxidant, orally ingestible carrier; antitumor and anticarcinogenic agents; aging resistance; storage stability |
| 08/27/2002 | US6440445 Methods and compounds for treatment of abnormal uterine bleeding |
| 08/27/2002 | US6440442 Hydrophilic polymer blends used for dry cow therapy |
| 08/27/2002 | US6440430 Oxyalkenylated silicone and silicone oil; stability; drugs, hygiene |
| 08/27/2002 | US6440428 Podophyllotoxin preparation containing triglycerides |
| 08/27/2002 | US6440418 Variable light and heavy amino acid sequences encoded by nucleic acid sequences; seq id no:24, 25 and 26; rheumatoid arthritis, multiple sclerosis, diabetes, and systemic lupus erythematosus; graft versus host disease; gene therapy |
| 08/27/2002 | US6440414 Fibrolase and novel acting thrombolytic agents suitable for liquid frozen state or lyophilization storage; metallo-proteinase fibrinolytic agent of seq.id no: 1, zinc stabilizer, buffer and optionally a bulking agent |
| 08/27/2002 | US6440399 Skin protection from uv light, microorganisms, chemicals; hydrophilic, lipophilic micronized inorganic pigment parti-cles; metal oxides coated with dimethylpolysiloxane, silica gel, aluminium hydroxide, alumina and/or silicon dioxide |
| 08/27/2002 | US6440394 Remineralizing-mineralizing oral products containing discrete cationic and anionic agglomerate components and method of use |
| 08/27/2002 | US6440393 Sdministering aerosolized drug in an air mixture containing up to about 10% carbon dioxide gas for increasing the deposition of aerosolized drug in the respiratory tract of an individual or animal |
| 08/27/2002 | US6440392 Citric acid or salt stabilized solution; high bioavail-ability; treatment of conditions including osteoporosis, paget's disease and malignant hypercalcemia |
| 08/27/2002 | US6440391 Management of snoring by oral administration of dimethyl sulfone |
| 08/27/2002 | US6440337 Method and apparatus for the formation of particles |
| 08/27/2002 | US6440336 Method for producing a powder product from a liquid substance or mixture of substances |
| 08/27/2002 | CA2126669C Intrabuccally disintegrating preparation and production thereof |
| 08/27/2002 | CA2045955C Indole derivatives |
| 08/27/2002 | CA2025703C Pulsatile once-a-day delivery systems for minocycline |
| 08/27/2002 | CA2015838C Method of topically treating acne vulgaris |
| 08/22/2002 | WO2002064576A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 08/22/2002 | WO2002064565A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical |
| 08/22/2002 | WO2002064557A2 New crystal forms of oxcarbazepine and processes for their preparation |
| 08/22/2002 | WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals |
| 08/22/2002 | WO2002064543A2 Novel succinate salt of o-desmethyl-venlafaxine |
| 08/22/2002 | WO2002064356A1 A tablet press machine |
| 08/22/2002 | WO2002064189A2 Radiation cross-linked hydrogels |
| 08/22/2002 | WO2002064168A1 Targetted anti-tumor drug delivery systems |
| 08/22/2002 | WO2002064166A1 Formulation to enhance bioavailability of bioactive matrials and preparation method thereof |
| 08/22/2002 | WO2002064162A2 Vaccine for transcutaneous immunization |
| 08/22/2002 | WO2002064148A2 Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders |
| 08/22/2002 | WO2002064144A1 Aqueous suspension eyedrops and process for producing the same |
| 08/22/2002 | WO2002064133A1 Preparations for controlling concentration in blood |
| 08/22/2002 | WO2002064132A2 Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
| 08/22/2002 | WO2002064131A2 Inflammation-inhibiting compounds |
| 08/22/2002 | WO2002064127A1 Methods and clinical devices for the inhibition or prevention of mammalian cell growth |
| 08/22/2002 | WO2002064124A2 Medicament formulation containing a muscarinic agonist |
| 08/22/2002 | WO2002064123A2 Method and device for producing thin wafers from a film of active ingredients |
| 08/22/2002 | WO2002064122A1 Bioactive and biocompatible conjugates with magnetic properties and a method for producing the same |
| 08/22/2002 | WO2002064121A1 Novel modified released formulation |
| 08/22/2002 | WO2002064120A1 Gel preparations for internal use |
| 08/22/2002 | WO2002064119A1 Tablets quickly disintegrated in oral cavity |
| 08/22/2002 | WO2002064118A1 Novel modified release formulation |
| 08/22/2002 | WO2002064117A1 Sterile composition and its preparation |
| 08/22/2002 | WO2002064116A2 Thermolabile liposome with controlled release temperature |
| 08/22/2002 | WO2002064115A1 Formulation for delivery of insulin and preparation method thereof |
| 08/22/2002 | WO2002064114A1 Novel ophthalmic compositions |
| 08/22/2002 | WO2002064113A1 Liquid formulations for the prevention and treatment of mucosal diseases and disorders |
| 08/22/2002 | WO2002064112A2 Therapeutic agents complexed with calcium phosphate and encased by casein |
| 08/22/2002 | WO2002064111A1 Vitamin/mineral complex |
| 08/22/2002 | WO2002064110A2 Carotenoid-loaded liposomes |
| 08/22/2002 | WO2002064109A2 Mucoadhesive pharmaceutical formulations |
| 08/22/2002 | WO2002064108A2 Delivery of biologically active agents |
| 08/22/2002 | WO2002064093A2 Stabilized pharmaceutical and thyroid hormone compositions and method of preparation |
| 08/22/2002 | WO2002064089A2 Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial ib-367 peptides |
| 08/22/2002 | WO2002064071A1 Device and method for anterior segment drug delivery |
| 08/22/2002 | WO2002064064A1 Injectable pharmaceutical composition comprising microparticles or microdroplets of camptothecin |
| 08/22/2002 | WO2002064062A2 Vertebroplasty injection device and bone cement therefor |
| 08/22/2002 | WO2002064046A2 A compound and method of treatment for fungal pathologies of the oral cavity |
| 08/22/2002 | WO2002064026A2 Treating pulmonary disorders with gaseous agent causing repletion of gsno |
| 08/22/2002 | WO2002064014A2 Endomural therapy |
| 08/22/2002 | WO2002063982A1 Composition and method for smoke detoxification |
| 08/22/2002 | WO2002063961A1 Composition and methods for modulation of vascular structure and/or function |
| 08/22/2002 | WO2002041874A3 Granulation process |
| 08/22/2002 | WO2002040021A3 Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines |
| 08/22/2002 | WO2002032869A3 Substituted heterocyclic compounds for treating multidrug resistance |
| 08/22/2002 | WO2002032404A3 Nanoparticles |
| 08/22/2002 | WO2002024160A3 Long acting antidepressant microparticles |
| 08/22/2002 | WO2002024143A3 Treating microbial infection of skin lesions |
| 08/22/2002 | WO2002017883A3 Milled particles |
| 08/22/2002 | WO2002015959A3 Compounds and compositions for delivering active agents |
| 08/22/2002 | WO2002004008A3 Methods of therapy with thrombin derived peptides |
| 08/22/2002 | WO2001093850A3 Methods and compositions using sulodexide for the treatment of diabetic nephropathy |
| 08/22/2002 | WO2000035423A9 Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same |
| 08/22/2002 | WO2000033979A9 Apparatus for separating particles of cohesive material according to size and process |
| 08/22/2002 | WO2000025749A9 Use of xanthan gums for preparing pharmaceutical compositions |
| 08/22/2002 | US20020115985 Drug delivery via conformal film |
| 08/22/2002 | US20020115976 Administration of therapeutic or diagnostic agents using interlabial pad |
| 08/22/2002 | US20020115726 Methods and compositions for treating depression and other disorders using optically pure (-) -bupropion |
| 08/22/2002 | US20020115725 Methods and compositions for regulating memory consolidation |
| 08/22/2002 | US20020115720 Especially applying the retinoid to a contact lens and placing the contact lens in the eye. |
| 08/22/2002 | US20020115718 Divalproex sodium tablets |